Expansion of scope of practice and diminishing revenues from dispensing are requiring pharmacists to increasingly adopt clinical care services into their practices. Pharmacists must be able to receive payment in order for provision of clinical care to be sustainable. The objective of this study is to update a previous systematic review by identifying remunerated pharmacist clinical care programs worldwide and reporting on uptake and patient care outcomes observed as a result.
Methods:
Literature searches were performed in several databases, including MEDLINE, Embase and International Pharmaceutical Abstracts, for papers referencing remuneration, pharmacy and cognitive services. Searches of the grey literature and Internet were also conducted. Papers and programs were identified up to December 2012 and were included if they were not reported in our previous review. One author performed data abstraction, which was independently reviewed by a second author. All results are presented descriptively.
Results:
Sixty new remunerated programs were identified across Canada, the United States, Europe, Australia and New Zealand, ranging in complexity from emergency contraception counseling to minor ailments schemes and comprehensive medication management. In North America, the average fee provided for a medication review is $68.86 (all figures are given in Canadian dollars), with $23.37 offered for a follow-up visit and $15.16 for prescription adaptations. Time-dependent fees were reimbursed at $93.60 per hour on average. Few programs evaluated uptake and outcomes of these services but, when available, indicated slow uptake but improved chronic disease markers and cost savings.
Discussion:
Remuneration for pharmacists’ clinical care services is highly variable, with few programs reporting program outcomes. Programs and pharmacists are encouraged to examine the time required to perform these activities and the outcomes achieved to ensure that fees are adequate to sustain these patient care activities.
Get full access to this article
View all access options for this article.
References
1.
HeplerCDStrandLM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm1990;47:533-43.
MahERosenthalMTsuyukiRT. Study of understanding pharmacists’ perspectives on remuneration and transition toward chronic disease management (SUPPORT-CDM): results of an Alberta-wide survey of community pharmacists. Can Pharm J (Ott)2009;142:136-44.
4.
RobertsASBenrimojSIChenTF. Implementing cognitive services in community pharmacy: a review of faciliators used in practice change. Int J Pharm Pract2006;14:163-70.
5.
SantschiVChioleroABurnandB. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med2011;171:1441-53.
6.
NkansahNMostovetskyOYuC. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev2010;(7):CD000336.
7.
ChanPGrindrodKABougherD. A systematic review of remuneration systems for clinical pharmacy care services. Can Pharm J (Ott)2008;141:102-12.
8.
MoherDCookDJEastwoodS. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet1999;354:1896-900.
9.
HouleSKDGrindrodKAChatterleyTTsuyukiRT. Publicly funded remuneration for the administration of injections by pharmacists: an international review. Can Pharm J (Ott)2013;146:353-64.
Partnership to Assist with Cessation of Tobacco (PACT) homepage. Available: www.makeapact.ca (accessed Feb. 14, 2013).
25.
JacksonMGaspic-PiskovicMCiminoS. Description of a Canadian employer-sponsored smoking cessation program utilizing community pharmacy-based cognitive services. Can Pharm J2008;141(4):234-40.
State of Indiana. Medicaid Bulletin: implementation of smoking cessation treatment services. Available: www.in.gov/isdh/tpc/files/policyFile_76.pdf (accessed April 4, 2013).
Louisiana Department of Health and Hospitals. Declaration of Emergency—Professional Services Program Diabetes Self-Management Training. Available: www.doa.louisiana.gov/osr/emr/1209EMR076.pdf (accessed April 4, 2013).
De OliveiraDRBrummelARMillerDB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm2010;16:185-95.
51.
ThompsonCA. State-paid medication therapy management services succeed. Am J Health Syst Pharm2008;65:490-8.
North Carolina Health and Wellness Trust Fund. About ChecKmeds NC. Available: www.checkmedsnc.com/patients.aspx (accessed April 7, 2013).
63.
SarbackerGSpencerB. Physician opinion on pharmacist participation in direct patient care via the ChecKMeds NC program. J Am Pharm Assoc2009;49:237-8.
64.
North Carolina Department of Health and Human Services. North Carolina Medicaid Special Bulletin, May2006. Available: www.ncdhhs.gov/dma/bulletin/pharmacy.pdf (accessed May 20, 2013).
MichaelsNMJenkinsGFPrussDL. Retrospective analysis of community pharmacists’ recommendations in the North Carolina Medicaid medication therapy management program. J Am Pharm Assoc2010;50:347-53.
PintoSLBechtolRKumarJ. Evaluating clinical outcomes of an employer sponsored multi-center diabetes and hypertension medication therapy management program (MTMP) [Abstract]. Value Health2009;12:A140.
70.
PintoSLParthaG. Health care utilization and costs for a medication therapy management (MTM) program [Abstract]. Value Health2011;14:A50-51.
71.
PintoSLParthaGJaniaA. Medication therapy management improves health care utilization and costs for employers. Value Health2011;14:A47.
BarlasS. FDA considers a new paradigm for over-the-counter medications: More power—but more burdens—for pharmacists and pharmacies. Pharm Ther2012;37:300-5.
81.
GorshBKimYPraslaK. Clinical and economic evaluation of a diabetes medication management program: 2 year program update [Abstract]. Value Health2011;14:A101.
LeedhamRMottDKrelingD. Eleven-year trend analysis of Wisconsin Medicaid pharmaceutical care program paid claims [Abstract]. J Am Pharm Assoc2010;50:264.
88.
LookKMottDKrelingD. Characteristics of pharmacies participating in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007 [Abstract]. J Am Pharm Assoc2010;50:263.
89.
LookKAMottDALeedhamRK. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996-2007. J Manag Care Pharm2012;18:116-28.
90.
TraynorK. Wyoming program brings pharmacist consultations home. Am J Health Syst Pharm2004;61:760-761.
91.
BarnettMJFrankJShaneP. Characteristics of part D patients receiving medication therapy management program (MTMP) services: early support and findings from 3 open enrollment plans. J Manag Care Pharm2010;16:522.
92.
AltmanJS. Medication therapy management and the new practitioner. Am J Health Syst Pharm2007;64:590-2.
93.
BarnettMJFrankJWehringH. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm2009;15:18-31.
94.
DodsonSERuisingerJFHowardPA. Community pharmacy–based medication therapy management services: financial impact for patients. Pharmacy Practice2012;10:119-24.
95.
FoxDRiedLDKleinGE. A medication therapy management program’s impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. J Am Pharm Assoc (2003)2009;49:192-9.
96.
GonzalezJNogaM. Medication therapy management. J Manag Care Pharm2008;14(Suppl. S-c):S8-11.
97.
TouchetteDRBurnsALBoughMABlackburnJC. Survey of medication therapy management programs under Medicare Part D. J Am Pharm Assoc (2003)2006;46:683-91.
LeeEBraundRTordoffJ. Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008. New Zealand Med J2009;122(1293):26-35.
104.
BauldLChestermanJFergusonJJudgeK. A comparison of the effectiveness of group-based and pharmacy-led smoking cessation treatment in Glasgow. Addiction2009;104:308-16.
105.
BauldLBoydKABriggsAH. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine Tob Res2011;13:135-45.
McDonaldRCheraghi-SohiSSandersCAshcroftD. Professional status in a changing world: the case of medicines use reviews in English community pharmacy. Soc Sci Med2010;71:451-8.
112.
CowleyJGidmanWMcGregorL. Exploring community pharmacists’ experience and opinions of Medication Review services in England, Wales and Scotland [Abstract]. Int J Pharm Pract2010;18(Suppl. 2):88-9.
DavidsonMBennettSCubbinIVickersS. An early evaluation of the use made by patients in Cheshire of the Pharmacy Minor Ailments Scheme and its costs and impact on patient care [Abstract]. Int J Pharm Pract2009;17(Suppl. 2):B59-60.
KaaeSSondergaardBStif HaugbolleLTraulsenJM. Sustaining delivery of the first publicly reimbursed cognitive service in Denmark: a cross-case analysis. Int J Pharm Pract2010;18:21-7.
Community pharmacy EHC services: a review of uptake and users in one primary care organization 2008-2009 [Abstract]. Int J Pharm Pract2010;18(Suppl. 2):38-39.
FangGFarrisKKuhleC. Patient safety issues identified in the Iowa Priority Brown Bag medication assessment: the contribution of prescription, nonprescription and natural remedies [Abstract]. J Am Pharm Assoc (2003)2003;43:282-3.
142.
PindoliaVKStebelskyLRomainTM. Mitigation of medication mishaps via medication therapy management. Ann Pharmacother2009;43:611-20.
WinstonSLinY. Impact on drug cost and use of Medicare Part D of medication therapy management services delivered in 2007. J Am Pharm Assoc (2003)2009;49:813-20.
145.
BaqirWToddALearoydT. Cost effectiveness of community pharmacy minor ailment schemes [Abstract]. Int J Pharm Pract2010;18Suppl 2:3.
146.
TraynorK. Wyoming pharmacist consultation program ends, but idea survives elsewhere. Am J Health Syst Pharm2009;66:1428-31.
147.
PumtongSBoardmanHFAndersonCW. A multi-method evaluation of the Pharmacy First Minor Ailments Scheme. Int J Clin Pharm2011;33:573-81.
148.
PumtongSBoardmanHFAndersonCW. Pharmacists’ perspectives on the Pharmacy First Minor Ailments Scheme. Int J Pharm Pract2008;16:73-80.
RosenthalMAustinZTsuyukiRT. Are pharmacists the ultimate barrier to pharmacy practice change?Can Pharm J (Ott)2010;143:37-42.
152.
FrankelGECAustinZ. Responsibility and confidence: identifying barriers to advanced pharmacy practice. Can Pharm J (Ott)2013;146:155-61.
153.
HerbertKEUrmieJMNewlandBAFarrisKB. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Social Adm Pharm2006;2:299-314.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
